(Q33278313)

25 July 2017

title

Blood flow modification in the SCCVII tumor: effects of 5-hydroxytryptamine, hydralazine, and propranolol (English)

1 reference

25 July 2017

Blood flow modification in the sccvii tumor: Effects of 5-Hydroxytryptamine, hydralazine, and propanolol (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90854-B

12 November 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90854-B

12 November 2022

author name string

C. E. Peters

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735679

12 November 2022

D. J. Chaplin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735679

12 November 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

full work available at URL

25 July 2017

https://api.elsevier.com/content/article/PII:036030169290854B?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90854-B

https://api.elsevier.com/content/article/PII:036030169290854B?httpAccept=text/plain

12 November 2022

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90854-B

International Journal of Radiation Oncology Biology Physics

12 November 2022

published in

1 reference

25 July 2017

volume

22

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

463-465

1 reference

Cell selection from a murine tumour using the fluorescent probe Hoechst 33342

25 July 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90854-B

Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT).

12 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90854-B

The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain

12 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90854-B

Drug induced perturbations in tumor blood flow: therapeutic potential and possible limitations

12 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90854-B

Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo

12 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90854-B

The effects of oral hydralazine on blood pressure, cardiac output and peripheral resistance with respect to dose, age and acetylator status

12 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90854-B

12 November 2022

Identifiers

0 references

1 reference